Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors-Reference-Cited by-同舟云学术

Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors

Published:2015-09-30 Issue:32 Volume:6 Page:32368-32379
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Baldelli Elisa¹²,Bellezza Guido³,Haura Eric B.⁴,Crinó Lucio²,Cress W. Douglas⁴,Deng Jianghong¹,Ludovini Vienna²,Sidoni Angelo³,Schabath Matthew B.⁴,Puma Francesco⁵,Vannucci Jacopo⁵,Siggillino Annamaria²,Liotta Lance A.¹,Petricoin Emanuel F.¹,Pierobon Mariaelena¹

Affiliation:

1. Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA

2. Medical Oncology Division, S. Maria della Misericordia Hospital, Perugia, Italy

3. Department of Experimental Medicine, Section of Anatomic Pathology and Histology, Medical School, University of Perugia, Perugia, Italy

4. Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

5. Department of Thoracic Surgery, University of Perugia, Perugia, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling;Clinical Proteomics;2024-01-22

2. RHOA ^L57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling;Science Signaling;2023-12-19

3. Functional and biological heterogeneity of KRAS ^Q61 mutations;Science Signaling;2022-08-09

4. Accuracy of 18F-FDG in Detecting Stage I Lung Adenocarcinomas According to IASLC/ATS/ERS Classification;Heart, Lung and Circulation;2021-11

5. PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine;Journal for ImmunoTherapy of Cancer;2021-10